SMPDL3B contributes to gastric adenocarcinoma cells progression by promoting the infiltration of M2 macrophages

  • 0Department of Rheumatology and Immunology, Tianjin Medical University General Hospital, Tianjin Medical University, Tianjin, China.

|

|

Summary

This summary is machine-generated.

Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3B) is highly expressed in gastric adenocarcinoma (GAC), promoting tumor growth and invasion. Targeting SMPDL3B may offer new strategies for GAC diagnosis and treatment.

Area Of Science

  • Oncology
  • Molecular Biology
  • Immunology

Background

  • Gastric adenocarcinoma (GAC) presents significant morbidity and mortality, necessitating novel diagnostic markers and therapeutic targets.
  • Sphingomyelin phosphodiesterase acid-like 3b (SMPDL3B) is investigated for its role in GAC progression.

Purpose Of The Study

  • To investigate the expression of SMPDL3B in GAC.
  • To determine the effects of SMPDL3B on GAC tumor progression.

Main Methods

  • Analysis of GAC patient samples and cell lines (GES-1, SGC-7901, AGS, MGC-803, MSN-45).
  • Techniques included RT-qPCR, Western blot, immunohistochemistry, cell proliferation, migration, invasion assays, flow cytometry, and immune evaluation.
  • SMPDL3B knockdown and overexpression models were utilized.

Main Results

  • SMPDL3B expression was significantly elevated in GAC, correlating with poor prognosis.
  • SMPDL3B promoted GAC cell proliferation, migration, and invasion.
  • Bioinformatics analysis revealed SMPDL3B's association with M2 macrophage infiltration in the GAC tumor microenvironment, enhancing proliferation.

Conclusions

  • SMPDL3B plays a crucial role in GAC progression.
  • SMPDL3B holds potential as a biomarker for GAC diagnosis and prognosis.
  • Targeting SMPDL3B may represent a novel therapeutic strategy for GAC.